IL22 and alcoholic liver diseases: The ILC3-derived IL-22 production was found to be reduced in an alcoholic liver disease mouse model; IAA supplementation restored the IL-22 level and protected the mice from ethanol-induced steatohepatitis (Hendrikx et al., 2019).